Featured image of the article A new comprehensive report on halide solid electrolytes for li-ion batteries.

A new comprehensive patent landscape report on halide solid electrolytes for li-ion batteries

SOPHIA ANTIPOLIS, France – May 20, 2024 │ KnowMade, a leading provider of technology intelligence and IP analysis, proudly announces the release of its latest patent landscape report, Halide Solid Electrolytes for Li-ion Batteries. This report presents an in-depth analysis of the burgeoning field of halide solid electrolytes, a promising technology for the next generation[…]

Featured image of the post Recycling of Li-ion batteries: empower your understanding of the competitive and technological landscape thanks to patent analysis.

Recycling of Li-ion batteries: empower your understanding of the competitive and technological landscape thanks to patent analysis

SOPHIA ANTIPOLIS, France – May 14, 2024 │Dr. Filippo Farina is set to speak at AABC2024 tomorrow. Meet him in Strasbourg to discuss the following issues regarding battery recycling. Overall picture and next challenges to face The global growing demand for batteries has led to the increasing interest for lithium-ion batteries recycling. Players on the[…]

Featured image of the post Replicate Bioscience unveils promising clinical progress on self-amplifying RNA at ASGCT annual meeting.

Replicate Bioscience unveils promising clinical progress on self-amplifying RNA at ASGCT annual meeting

SOPHIA ANTIPOLIS, France – May 13, 2024 │ KnowMade actively follows therapeutic mRNA news for its Therapeutic mRNA patent monitor service! What’s new today? REPLICATE BIOSCIENCE develops novel self-amplifying RNA (or self-replicating or srRNA) technology for use across a range of application (i.e., infectious disease, oncology, or autoimmune disease). This clinical-stage company was already identified[…]

Featured image of Q12024 mRNA monitor Press release.

Q1 2024 IP Activity Reveals Growth and Litigation in Key mRNA Market

SOPHIA ANTIPOLIS, France – April 18, 2024 │ The quarterly report for the Q1 2024 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. What’s new this quarter? Q1 2024 IP Activity overview The IP activity during Q1 2024 follow 2023’s[…]